Arcturus Therapeutics Holdings Inc

NASDAQ:ARCT   3:59:54 PM EDT
37.55
+0.08 (+0.21%)
Earnings Announcements

Arcturus Therapeutics Holdings Q3 Loss Per Share $2.05

Published: 11/08/2021 21:06 GMT
Arcturus Therapeutics Holdings Inc (ARCT) - Q3 Loss per Share $2.05.
Q3 Earnings per Share View $-1.59 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15.87 Million
Adjusted EPS is expected to be -$1.68

Next Quarter Revenue Guidance is expected to be $46.63 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.